Compare AstraZeneca plc (AZN) vs Coursera Inc (COUR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Coursera Inc — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while Coursera Inc trades at $5.65 (market cap $1.50B). The key difference: AstraZeneca plc is far larger — about 165.4× Coursera Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Coursera Inc pays none. Which is the better fit depends on your goals.
| AZN | COUR | |
|---|---|---|
Market Cap | $248.14B | $1.50B |
Sector | Health | Consumer Staples |
52-Week High | $209.48 | $12.20 |
52-Week Low | $147.06 | $5.09 |
Enterprise Value | $275.41B | $759.54M |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →
